Funding · Company
Indapta Therapeutics Inc.
Houston, TXSoftware & Technology
Indapta Therapeutics Inc. of Houston, TX has disclosed $84M across 2 Form D offerings filed with the SEC between Feb 10, 2022 and Oct 14, 2025.
$84M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$51M
Form D · Oct 14, 2025 ↗
Q4 2025
· target $52M
$34M
Form D · Feb 10, 2022 ↗
Q1 2022
· target $67M
Filing details
HeadquartersHouston, TXIndustrySoftware & Technology (Other Technology)SEC CIK0001910175Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →